166 related articles for article (PubMed ID: 1997637)
21. Lipid profile in haemodialysis patients treated with recombinant human erythropoietin.
Prata MM; Madeira C; Vicente O; Miguel MJ
Nephrol Dial Transplant; 1998 Sep; 13(9):2345-7. PubMed ID: 9761520
[TBL] [Abstract][Full Text] [Related]
22. The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure.
Túri S; Németh I; Varga I; Bodrogi T; Matkovics B
Pediatr Nephrol; 1992 Nov; 6(6):536-41. PubMed ID: 1482641
[TBL] [Abstract][Full Text] [Related]
23. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise.
Russell G; Gore CJ; Ashenden MJ; Parisotto R; Hahn AG
Eur J Appl Physiol; 2002 Mar; 86(5):442-9. PubMed ID: 11882931
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patients.
Lebel M; Kingma I; Grose JH; Langlois S
J Am Soc Nephrol; 1998 Jan; 9(1):97-104. PubMed ID: 9440093
[TBL] [Abstract][Full Text] [Related]
25. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery.
Sowade O; Messinger D; Franke W; Sowade B; Scigalla P; Warnke H
Eur J Haematol; 1998 Apr; 60(4):252-9. PubMed ID: 9579879
[TBL] [Abstract][Full Text] [Related]
26. Recombinant human erythropoietin in autologous blood donors: a dose-finding study.
Biesma DH; Kraaijenhagen RJ; Dalmulder J; Marx JJ; Van De Wiel A
Br J Haematol; 1994 Jan; 86(1):30-5. PubMed ID: 8011544
[TBL] [Abstract][Full Text] [Related]
27. Effects of recombinant human erythropoietin on autologous blood donation before open heart surgery.
Schmoeckel M; Nollert G; Mempel M; Mempel W; Reichart B
Thorac Cardiovasc Surg; 1993 Dec; 41(6):364-8. PubMed ID: 8128466
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent effects of recombinant human erythropoietin on the reticulocyte population of rabbits.
Fuchs A; Eder H
Arzneimittelforschung; 1992 Oct; 42(10):1266-8. PubMed ID: 1472149
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study.
Balleari E; Rossi E; Clavio M; Congiu A; Gobbi M; Grosso M; Secondo V; Spriano M; Timitilli S; Ghio R
Ann Hematol; 2006 Mar; 85(3):174-80. PubMed ID: 16408206
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia in children with malignant solid tumours.
Csáki C; Ferencz T; Schuler D; Borsi JD
Eur J Cancer; 1998 Feb; 34(3):364-7. PubMed ID: 9640223
[TBL] [Abstract][Full Text] [Related]
31. Treatment of anaemia in haemodialysis patients with erythropoietin: long-term effects on exercise capacity.
Bárány P; Freyschuss U; Pettersson E; Bergström J
Clin Sci (Lond); 1993 Apr; 84(4):441-7. PubMed ID: 8482049
[TBL] [Abstract][Full Text] [Related]
32. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
[TBL] [Abstract][Full Text] [Related]
33. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
[TBL] [Abstract][Full Text] [Related]
34. Erythropoiesis and erythrocyte age distribution in hemodialysis patients undergoing erythropoietin therapy.
Hampl H; Riedel E; Scigalla P; Stabell U; Wendel G
Blood Purif; 1990; 8(3):117-25. PubMed ID: 2244989
[TBL] [Abstract][Full Text] [Related]
35. rh-erythropoietin stimulates immature reticulocyte release in man.
Major A; Bauer C; Breymann C; Huch A; Huch R
Br J Haematol; 1994 Jul; 87(3):605-8. PubMed ID: 7993803
[TBL] [Abstract][Full Text] [Related]
36. Kinetics and haematological effects of erythropoietin in horses.
Jaussaud P; Audran M; Gareau RL; Souillard A; Chavanet I
Vet Res; 1994; 25(6):568-73. PubMed ID: 7889038
[TBL] [Abstract][Full Text] [Related]
37. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis.
Németh I; Túri S; Haszon I; Bereczki C
Pediatr Nephrol; 2000 Jan; 14(1):13-7. PubMed ID: 10654322
[TBL] [Abstract][Full Text] [Related]
38. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.
Wilber RL
Sports Med; 2002; 32(2):125-42. PubMed ID: 11817997
[TBL] [Abstract][Full Text] [Related]
39. Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.
Durussel J; Daskalaki E; Anderson M; Chatterji T; Wondimu DH; Padmanabhan N; Patel RK; McClure JD; Pitsiladis YP
PLoS One; 2013; 8(2):e56151. PubMed ID: 23418527
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin, folic acid deficiency and hyperhomocysteinemia: is there a possible relationship in chronically hemodialyzed patients?
Korzets A; Ori Y; Chagnac A; Weinstein T; Herman M; Zevin D; Malachi T; Gafter U
Clin Nephrol; 2000 Jan; 53(1):48-54. PubMed ID: 10661482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
